Trials / Completed
CompletedNCT00576238
Skin Tolerance Study of Betamethasone Creams in Atopic Eczema and the Preventative Properties of a Moisturiser
A Multi Centre, Parallel, Randomised Study of the Skin Tolerance of Betamethasone Creams on Atopic Eczema and the Influence of Moisturiser Treatment on the Recurrence of Eczema
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 55 (actual)
- Sponsor
- ACO Hud Nordic AB · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Topical steroid creams as well as moisturizing creams are important parts of the treatment strategy of atopic eczema. This study aims to investigate the tolerance of a new strong steroid cream in comparison to an already marketed reference cream with equal amount of active but with different cream vehicle. The second part of the study will investigate the possible preventative property of a moisturizing cream on skin that has been previously cleared from eczema.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | betamethasone valerate | Topical application according to a fixed schedule for three weeks |
| DRUG | betamethasone valerate | Topical application according to a fixed schedule for three weeks |
| DRUG | urea | Topical application twice daily for up to 6 months |
Timeline
- Start date
- 2004-01-01
- Completion
- 2008-02-01
- First posted
- 2007-12-19
- Last updated
- 2008-10-13
Locations
5 sites across 1 country: Sweden
Source: ClinicalTrials.gov record NCT00576238. Inclusion in this directory is not an endorsement.